OrganiGram (OGI)
(Delayed Data from NSDQ)
$1.47 USD
-0.07 (-4.55%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $1.46 -0.01 (-0.68%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
OGI 1.47 -0.07(-4.55%)
Will OGI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OGI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OGI
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
Why OrganiGram (OGI) Might Surprise This Earnings Season
OGI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
Organigram (OGI) Grows in Cannabis Space With SHRED X Heavies
Canopy Growth Corporation (CGC) Reports Q4 Loss, Lags Revenue Estimates
Other News for OGI
Organigram's Promising Results From Nanoemulsion Technology Study To Improve Cannabis Edibles
Cannabis Stock Movers For August 8, 2024
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
Organigram’s Nanoemulsion Tech Revolutionizes Cannabis Consumption
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now